[1]
2026. Assessment of Efficacy and Safety of Tirofiban in Acute Coronary Syndrome Patients Following Percutaneous Coronary Intervention: A Prospective Observational Study. The Insight. 9, 01 (Mar. 2026), 167–171. DOI:https://doi.org/10.5281/.